Evidence map›Paper›PMID 40754904›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2025

[A preoperative prediction model for pelvic lymph node metastasis in prostate cancer: Integrating clinical characteristics and multiparametric MRI].

Z Wang, S Yu, H Zheng, J Tao, Y Fan, X Zhang

Abstract readEnglish Abstract
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Z WangDepartment of Urology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
S YuDepartment of Urology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
H ZhengDepartment of Urology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
J TaoDepartment of Urology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
Y FanDepartment of Urology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
X ZhangDepartment of Urology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze the clinical features associated with pelvic lymph node metastasis (PLNM) in prostate cancer and to construct a preoperative prediction model for PLNM, thereby reducing unnecessary extended pelvic lymph node dissection (ePLND).

methodsBased on predefined inclusion and exclusion criteria, 344 patients who underwent radical prostatectomy and ePLND at the First Affiliated Hospital of Zhengzhou University between 2014 and 2024 were retrospectively enrolled, among whom, 77 patients (22.4%) were pathologically confirmed to have lymph node-positive disease. The clinical characteristics, MRI reports, and pathological results were collected. The data were then randomly divi-ded into a training cohort (241 cases, 70%) and a validation cohort (103 cases, 30%). Univariate and multivariate Logistic regression analysis were employed to construct a preoperative prediction model for PLNM.

resultsUnivariate Logistic regression analysis revealed that total prostate specific antigen (tPSA) (

conclusionPercentage of positive biopsy cores, PI-RADS score and MRI-LNI are independent risk factors for PLNM. The constructed multivariate model significantly improves predictive efficacy, offering a valuable tool to guide clinical decisions on ePLND.

Indexed as

Lymphatic MetastasisLymph NodesMultiparametric Magnetic Resonance ImagingProstatic NeoplasmsAgedHumansLogistic ModelsLymph Node ExcisionMagnetic Resonance ImagingMaleMiddle AgedNomogramsPelvisPreoperative PeriodProstatectomyProstate-Specific AntigenProstate-Specific AntigenBiopsyLymphatic metastasisMultiparametric magnetic resonance imagingProstatic neoplasms

Identifiers

PMID40754904
PMCPMC12330916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.